Rare extreme polygenic risk scores strongly indicate Alzheimer's disease risk
Background:
Alzheimer's disease (AD) pathology often accumulates years before memory loss, creating a need to identify high-risk individuals presymptomatically. Polygenic risk scores (PRS) stratify AD risk, but individual-level predictions remain uncertain. Extreme PRS may identify high-risk individuals independent of APOE .
Methods:
Using GenoPred, extreme tails of 1,752 PRS methods were evaluated across four genetic ancestries using 11,200 autopsy- or clinically-defined AD cases and 19,321 controls (age ≥65) from the AD Sequencing Project (ADSP) Release 5.
Results:
Individuals in the extreme upper PRS tail were significantly enriched for AD in all ancestries: Admixed American ( P adj =0.02727), African ( P adj =0.004827), East Asian ( P adj =0.02824), and European ( P adj =2.3068×10 -13 ). No controls were observed among the 42 European- and 12 African-ancestry individuals with extreme PRS. Extreme PRS spanned APOE diplotypes; 38% occurred in non- APOE ε4 carriers.
Conclusions:
Rare subsets of individuals at the most extreme PRS thresholds have markedly elevated AD enrichment across ancestries and APOE diplotypes.
Data Availability:
All data are available through the ADSP, which is managed by The National Institute on Aging Genetics of Alzheimer's Disease Data Storage Site (NIAGADS).
More Related Videos
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
Related Concept Videos
Alzheimer Disease l: Introduction
Polygenic Traits
Polygenic Traits
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Alzheimer Disease ll: Pathophysiology
